- Home
- CLBK vs KOD Comparison
CLBK vs KOD Comparison
Compare CLBK & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CLBK | KOD |
|---|---|---|
| Founded | 1927 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.3B |
| IPO Year | 2017 | 2018 |
Fundamental Metrics
Financial Performance| Metric | CLBK | KOD |
|---|---|---|
| Price | $17.34 | $23.59 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 7 |
| Target Price | $17.00 | ★ $28.29 |
| AVG Volume (30 Days) | 234.0K | ★ 510.9K |
| Earning Date | 05-04-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 563.64 | 32.60 |
| EPS | ★ 0.51 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $3.97 | N/A |
| Revenue Next Year | $11.43 | N/A |
| P/E Ratio | $34.65 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.64 | $1.92 |
| 52 Week High | $18.87 | $31.18 |
Technical Indicators
Market Signals| Indicator | CLBK | KOD |
|---|---|---|
| Relative Strength Index (RSI) | 43.95 | 43.81 |
| Support Level | $14.68 | $21.19 |
| Resistance Level | $18.72 | $26.21 |
| Average True Range (ATR) | 0.45 | 1.71 |
| MACD | -0.15 | -0.27 |
| Stochastic Oscillator | 17.27 | 16.86 |
Price Performance
Historical ComparisonAbout CLBK Columbia Financial Inc.
Columbia Financial Inc is a federally chartered savings bank that serves the financial needs of depositors and the local community as a community-minded, customer service-focused institution. It offers traditional financial services to businesses and consumers. It attracts deposits from the general public and uses those funds to originate a variety of loans, including multifamily and commercial real estate loans, commercial business loans, one-to-four family real estate loans, construction loans, home equity loans and advances, and other consumer loans, and also offers a broad range of insurance products, investment solutions, and wealth management services.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.